AMVUTTRA

Serial Number 90151672
Registration 6840129
700

Registration Progress

Application Filed
Sep 1, 2020
Under Examination
Mar 30, 2021
Approved for Publication
Feb 2, 2021
Published for Opposition
Feb 2, 2021
Registered
Sep 6, 2022

Basic Information

Serial Number
90151672
Registration Number
6840129
Filing Date
September 1, 2020
Registration Date
September 6, 2022
Published for Opposition
February 2, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 6, 2022
Registration
Registered
Classes
005

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
300 Third Street
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Sarah Anne Keefe

USPTO Deadlines

Next Deadline
1155 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-09-06)
Due Date
September 06, 2028
Grace Period Ends
March 06, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description
Sep 6, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 6, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER
Aug 4, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 3, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 3, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Aug 1, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 15, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 15, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 15, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 15, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 15, 2022 IUAF S USE AMENDMENT FILED
Jul 15, 2022 EISU I TEAS STATEMENT OF USE RECEIVED
Feb 22, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 18, 2022 EX2G S SOU EXTENSION 2 GRANTED
Feb 18, 2022 EXT2 S SOU EXTENSION 2 FILED
Feb 18, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 18, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 16, 2021 EX1G S SOU EXTENSION 1 GRANTED
Sep 16, 2021 EXT1 S SOU EXTENSION 1 FILED
Sep 16, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 30, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 2, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 2, 2021 PUBO A PUBLISHED FOR OPPOSITION
Jan 13, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 30, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 30, 2020 DOCK D ASSIGNED TO EXAMINER
Oct 7, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 4, 2020 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of amyloidosis
First Use Anywhere: Jul 1, 2022
First Use in Commerce: Jul 5, 2022

Classification

International Classes
005